A grantee shall execute a grant agreement or loan agreement with the Corporation, in a form prescribed by the Corporation, that: Makes disbursement of financial assistance contingent on evidence of IRB approval of the State-funded stem cell research described in the application; Acknowledges, as appropriate, that an award of financial assistance beyond the current fiscal year may be contingent on future appropriations to the Fund; Establishes the scope of the State's ownership or other financial interest in the commercialization and other benefits of the results, products, inventions, and discoveries of the State-funded stem cell research described in the application; Discusses, as appropriate, other matters related to intellectual property; and Contains other assurances, as determined by the Corporation, related to the grantee's compliance with applicable law and the terms of the financial assistance. A grantee shall, upon request, provide information to the Commission and Corporation reasonably related to the oversight of an award of financial assistance and the progress and results of the State-funded stem cell research.